Financial Statements · Financial Reporting
AS Bravo Pharmaceuticals
Official identifier 14159974Record date 31 Dec 2021
EstoniaReport
- Legal formThe legal or organisational form recorded by the Estonian Business Register. Learn more
- AS
- Report status
- Registered
Dates
- Reporting year
- 2021
- Period start
- 1 Jan 2021
- Submitted date
- 21 Jun 2022
Report
- Consolidated
- No
- Audited
- No
Financial metrics
| Statement | Metric | Value |
|---|---|---|
| Balance sheet | Assets | 328,880 |
| Balance sheet | Cash and cash equivalents | 5,045 |
| Balance sheet | Current assets | 62,375 |
| Balance sheet | Current liabilities | 143,729 |
| Balance sheet | Equity | 185,151 |
| Balance sheet | Share capital at nominal value | 50,200 |
| Balance sheet | Non-current assets | 266,505 |
| Balance sheet | Non-current liabilities | 0 |
| Balance sheet | Retained earnings (loss) from previous periods | 16,664 |
| Income statement scheme 1 | Depreciation and impairment of non-current assets | -2,717 |
| Income statement scheme 1 | Labour costs | -30,462 |
| Income statement scheme 1 | Revenue | 30,158 |
| Income statement scheme 1 | Annual period profit / loss | -57,313 |
| Income statement scheme 1 | Operating profit (loss) | -57,444 |
| Income statement scheme 1 | Profit (loss) before income tax | -57,313 |
| Profit distribution proposal | Retained earnings (loss) from previous periods | 16,664 |
| Note: Labour costs | Employees | 2 |
| Note: Labour costs | Labour costs | 30,462 |
Linked company
Company: AS Bravo Pharmaceuticals